Organization · Venture Capital
우리벤처파트너스
WOORI Venture Partners is a venture capital firm based in Seoul, South Korea, focusing on technology and healthcare investments. Founded in 1981, it manages a significant portfolio and aims to support sustainable growth for its companies.
Overview
What 우리벤처파트너스 does
What 우리벤처파트너스 is
WOORI Venture Partners is a venture capital firm based in Seoul, South Korea, focusing on technology and healthcare investments. Founded in 1981, it manages a significant portfolio and aims to support sustainable growth for its companies.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 1981
- Approximate age
- About 45 years
- Structured capabilities
- Funder
- Last reviewed
- May 1, 2026
Official channels
Find 우리벤처파트너스 elsewhere
Open the official website or a supported primary organization account.
Capability profile
우리벤처파트너스 as a funder
Investment thesis
WOORI Venture Partners focuses on stable, long-term performance and active value creation, supporting portfolio companies to achieve sustainable growth. The firm aims to bridge Korean and U.S. innovation, particularly in technology and healthcare sectors.
Focus narrative
WOORI Venture Partners invests across various sectors, with a particular emphasis on technology and healthcare. The firm manages 354 portfolio companies and aims to create value through active support and alignment of interests with its partners.
Value beyond capital
WOORI Venture Partners adds value to its portfolio companies through active management, strategic guidance, and leveraging its extensive network within the WOORI Financial Group. The firm focuses on aligning interests with its partners to drive sustainable growth and success.
Focus and fit
- Stages
- Seed · Series A · Series B · Pre-IPO
- Sectors
- Artificial IntelligenceHealthcareBiotech & Life SciencesFintechConsumerEnergyMobility & TransportationRobotics & Autonomous Systems
- Regions
- Global · North America · Asia
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 354
Portfolio context
Notable portfolio companies include: Beyond Bio: Develops new medicine candidates for anticancer drugs and treatments for Alzheimer’s. CellID: Focuses on immunotherapy for difficult-to-treat cancers and infectious diseases. Scatter Lab: Provides an application called 'Ginger' that analyzes emotional changes in couples based on chat records. ASTA: Develops mass spectroscopes for diagnosing infectious diseases and cancer. Obigo: Offers integrated solutions for HTML5-based in-vehicle infotainment systems.
Common questions
What to know about 우리벤처파트너스
Upseed classifies 우리벤처파트너스 under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 1, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.